74117-3
Adalimumab [Mass/volume] in Serum or Plasma
Active
Part Description
LP173592-9 Adalimumab
Adalimumab is a human monoclonal antibody that binds tumor necrosis factor alpha (TNFα). TNFα is a cell signaling protein that, when present in excess, may lead to the development of inflammatory immune diseases including Crohn's disease, rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Adalimumab inactivates TNFα by binding to the TNFα receptor. PMID: 23943614 Treatment with adalimumab does not necessitate laboratory monitoring though association with increased transamines and pancytopenia may argue for intermittant blood cell counts and liver function tests. Adalimumab has been associated with serious infections including the reactivation of tuberculosis and deep fungal infections as well as other rare side effects, including lymphoma, heart failure and demyelinating disease. PMID: 16011443
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Adalimumab:
MCnc: Pt: Ser/Plas: Qn: - Long Common Name
- Adalimumab [Mass/volume] in Serum or Plasma
- Short Name
- Adalimumab SerPl-mCnc
- Display Name
- Adalimumab [Mass/Vol]
- Consumer Name Alpha Get Info
- Adalimumab, Blood
Part Model Get Info
- Component
- Adalimumab
LP173592-9
- Analyte
- Adalimumab
LP173592-9
- Component Numerator
- Adalimumab
LP173592-9
- Component Numerator Core
- Adalimumab
LP173592-9
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- NULL
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.46
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 3133
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 99781-7 | Adalimumab and Adalimumab Ab panel - Serum or Plasma by Immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG28982-3 | Adalimumab| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| ar-JO | Arabic (Jordan) | الأداليموماب ( بتقنية الكتلة / الحجم ) في المصل أو البلازما |
| cs-CZ | Czech (Czechia) | Adalimumab: |
| de-AT | German (Austria) | Synonyms: Adalimumab |
| de-DE | German (Germany) | Adalimumab: |
| el-GR | Greek (Greece) | Αδαλιμουμάμπη: Synonyms: DRUG/TOX MCnc Pt Qn Αδαλιμουμάμπη Ορός Ορός/Πλάσμα Πλάσμα |
| es-ES | Spanish (Spain) | Adalimumab: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | Adalimumab: |
| fr-FR | French (France) | Adalimumab: |
| it-IT | Italian (Italy) | Adalimumab: Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | adalimumab: |
| pl-PL | Polish (Poland) | Adalimumab: |
| ru-RU | Russian (Russian Federation) | Адалимумаб: Synonyms: Количественный Массовая концентрация Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
| tr-TR | Turkish (Turkey) | Adalimumab: |
| zh-CN | Chinese (China) | 阿达木单抗: Synonyms: Adalimumab 单抗; |
Example Units
| Unit | Source |
|---|---|
| ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://